{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:10:18Z","timestamp":1784149818675,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Investitionsbank Berlin\/EFRE","award":["10198849"],"award-info":[{"award-number":["10198849"]}]},{"name":"Zentrales Innovationsprogramm Mitterstand","award":["KK5175802AP2"],"award-info":[{"award-number":["KK5175802AP2"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>miRNAs, small non-coding RNAs, play key roles in gene regulation, cell differentiation and tissue development. They influence viral infection outcomes by directly interacting with viral genomes or modifying the host microenvironment. This study demonstrates miRNAs' ability to selectively suppress transcriptionally active erythroparvovirus, highlighting their potential in antiviral therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Seventy-five endomyocardial biopsy (EMB) specimens from patients with unexplained heart failure were analysed. The samples included 19 with dilated cardiomyopathy and inflammation (DCMi), 12 with dilated cardiomyopathy (DCM), 25 with inflammation and active erythroparvovirus infection, 13 with active erythroparvovirus infection only and 6 from undiagnosed patients as controls. miRNA expression was measured using TaqMan assays. miR-98, miR-222, miR-106b and miR-197 were significantly upregulated in patients with transcriptionally active erythroparvovirus infection, independent of inflammation (P &amp;lt; 0.005). These miRNAs differentiated these patients from all other groups with over 90% specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These specific miRNAs offer a novel diagnostic tool for active erythroparvovirus infections and hold promise as therapeutic targets, providing safer alternatives to traditional antiviral treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15194","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:40:41Z","timestamp":1739968841000},"page":"1872-1882","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Discovery of miRNAs Unique to Actively Transcribed Erythroparvovirus Infection in Heart Failure Patients"],"prefix":"10.1093","volume":"12","author":[{"given":"Ganna","family":"Aleshcheva","sequence":"first","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Salih","sequence":"additional","affiliation":[{"name":"BHT \u2013 Berliner Hochschule f\u00fcr Technik , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baumeier","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Escher","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Berlin ,","place":["Germany"]},{"name":"DHZC (German Heart Centre of Charit\u00e9) , Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Thomas","family":"Bock","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Robert Koch Institute , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schultheiss","sequence":"additional","affiliation":[{"name":"Institute for Cardiac Diagnostics and Therapy (IKDT) , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"2026021804245996800_ehf215194-bib-0001","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19\u2013associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N Engl J Med"},{"key":"2026021804245996800_ehf215194-bib-0002","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026021804245996800_ehf215194-bib-0003","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/cvr\/cvab315","article-title":"Cardiovascular consequences of viral infections: from COVID to other viral diseases","volume":"117","author":"Schultheiss","year":"2021","journal-title":"Cardiovasc Res (Oxford University Press)"},{"key":"2026021804245996800_ehf215194-bib-0004","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/ejhf.1560","article-title":"Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence","volume":"21","author":"Tsch\u00f6pe","year":"2019","journal-title":"Eur J Heart Fail (John Wiley & Sons, Ltd)"},{"key":"2026021804245996800_ehf215194-bib-0005","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ejhf.2082","article-title":"Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial","volume":"23","author":"Hazebroek","year":"2020","journal-title":"Eur J Heart Fail (England)"},{"key":"2026021804245996800_ehf215194-bib-0006","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cardfail.2018.07.466","article-title":"Parvovirus B19 in endomyocardial biopsy of patients with idiopathic dilated cardiomyopathy: foe or bystander?","volume":"25","author":"Hjalmarsson","year":"2019","journal-title":"J Card Fail"},{"key":"2026021804245996800_ehf215194-bib-0007","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78597-4","article-title":"Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure","volume":"10","author":"Pietsch","year":"2020","journal-title":"Sci Rep"},{"key":"2026021804245996800_ehf215194-bib-0008","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/ejhf.665","article-title":"Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature","volume":"18","author":"Verdonschot","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026021804245996800_ehf215194-bib-0009","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121898","article-title":"Transcriptional active parvovirus B19 infection predicts adverse long-term outcome in patients with non-ischemic cardiomyopathy","volume":"9","author":"Escher","year":"2021","journal-title":"Biomedicine"},{"key":"2026021804245996800_ehf215194-bib-0010","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00395-013-0372-y","article-title":"A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression","volume":"108","author":"Kuhl","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2026021804245996800_ehf215194-bib-0011","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026021804245996800_ehf215194-bib-0012","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"2026021804245996800_ehf215194-bib-0013","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00109-008-0341-3","article-title":"miRNAs at the heart of the matter","volume":"86","author":"Wang","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"2026021804245996800_ehf215194-bib-0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13619-021-00077-5","article-title":"miRNA in cardiac development and regeneration","volume":"10","author":"Ouyang","year":"2021","journal-title":"Cell Regen"},{"key":"2026021804245996800_ehf215194-bib-0015","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00059-012-3656-3","article-title":"miRNA as activity markers in parvo B19 associated heart disease","volume":"37","author":"K\u00fchl","year":"2012","journal-title":"Herz"},{"key":"2026021804245996800_ehf215194-bib-0016","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jcmm.17789","article-title":"Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure","volume":"27","author":"Zhang","year":"2023","journal-title":"J Cell Mol Med (John Wiley & Sons, Ltd)"},{"key":"2026021804245996800_ehf215194-bib-0017","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","article-title":"microRNA-21\u2013dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload","volume":"143","author":"Ramanujam","year":"2021","journal-title":"Circulation American Heart Association"},{"key":"2026021804245996800_ehf215194-bib-0018","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/cells11040594","article-title":"Anti-microRNA-21 therapy on top of ACE inhibition delays renal failure in Alport syndrome mouse models","volume":"11","author":"Rubel","year":"2022","journal-title":"Cells"},{"key":"2026021804245996800_ehf215194-bib-0019","doi-asserted-by":"publisher","DOI":"10.1177\/17539447231182548","article-title":"MiR-21 and tocilizumab interactions improve COVID-19 myocarditis outcomes","volume":"17","author":"Heydari","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2026021804245996800_ehf215194-bib-0020","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8853748","article-title":"Therapeutic value of miRNAs in coronary artery disease","volume":"2021","author":"Sheikh","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2026021804245996800_ehf215194-bib-0021","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01494","article-title":"miR-133: a suppressor of cardiac remodeling?","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"2026021804245996800_ehf215194-bib-0022","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/ijms21030700","article-title":"Potential clinical implications of miR-1 and miR-21 in heart disease and cardioprotection","volume":"21","author":"Kura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026021804245996800_ehf215194-bib-0023","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Future Med Chem"},{"key":"2026021804245996800_ehf215194-bib-0024","doi-asserted-by":"publisher","first-page":"2648a","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026021804245996800_ehf215194-bib-0025","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5543\/tkda.2015.47750","article-title":"Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment","volume":"43","author":"Escher","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2026021804245996800_ehf215194-bib-0026","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction","volume":"111","author":"Kuhl","year":"2005","journal-title":"Circulation"},{"key":"2026021804245996800_ehf215194-bib-0027","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.14010","article-title":"Viral myocarditis","volume":"144","author":"K\u00fchl","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"2026021804245996800_ehf215194-bib-0028","article-title":"microRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease","volume":"10","author":"Denk","year":"2015","journal-title":"PLoS One Public Library of Science"},{"key":"2026021804245996800_ehf215194-bib-0029","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01197","article-title":"microRNA biomarkers for infectious diseases: from basic research to biosensing","author":"Tribolet","year":"2020","journal-title":"Front Microbiol"},{"key":"2026021804245996800_ehf215194-bib-0030","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of microRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"2026021804245996800_ehf215194-bib-0031","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/gb-2014-15-3-r51","article-title":"Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs","volume":"15","author":"Martin","year":"2014","journal-title":"Genome Biol"},{"key":"2026021804245996800_ehf215194-bib-0032","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells MDPI"},{"key":"2026021804245996800_ehf215194-bib-0033","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021804245996800_ehf215194-bib-0034","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00155.2018","article-title":"microRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling and dysfunction","volume":"315","author":"Syed","year":"2018","journal-title":"Am J Physiol Metab"},{"key":"2026021804245996800_ehf215194-bib-0035","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol"},{"key":"2026021804245996800_ehf215194-bib-0036","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a MicroRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science (American Association for the Advancement of Science)"},{"key":"2026021804245996800_ehf215194-bib-0037","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation (American Heart Association)"},{"key":"2026021804245996800_ehf215194-bib-0038","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ijcard.2016.12.171","article-title":"Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy","volume":"230","author":"Zhou","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026021804245996800_ehf215194-bib-0039","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s12250-021-00441-4","article-title":"MicroRNA-324-3p plays a protective role against Coxsackievirus B3-induced viral myocarditis","volume":"36","author":"Liu","year":"2021","journal-title":"Virol Sin"},{"key":"2026021804245996800_ehf215194-bib-0040","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/iid3.392","article-title":"MicroRNA-425-3p inhibits myocardial inflammation and cardiomyocyte apoptosis in mice with viral myocarditis through targeting TGF-\u03b21","volume":"9","author":"Li","year":"2021","journal-title":"Immunity, Inflamm Dis"},{"key":"2026021804245996800_ehf215194-bib-0041","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s13577-023-00867-w","article-title":"Beauty and the beast: host microRNA-155 versus SARS-CoV-2","volume":"36","author":"Papadopoulos","year":"2023","journal-title":"Hum Cell"},{"key":"2026021804245996800_ehf215194-bib-0042","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265670","article-title":"Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract","volume":"17","author":"Farr","year":"2022","journal-title":"PLoS One (Public Library of Science)"},{"key":"2026021804245996800_ehf215194-bib-0043","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40265-021-01474-5","article-title":"MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19","volume":"81","author":"Hum","year":"2021","journal-title":"Drugs"},{"key":"2026021804245996800_ehf215194-bib-0044","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026021804245996800_ehf215194-bib-0045","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1128\/AAC.04220-14","article-title":"In vitro antiviral activity and preclinical and clinical resistance profile of Miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122","volume":"59","author":"Ottosen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026021804245996800_ehf215194-bib-0046","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1128\/AAC.04220-14","article-title":"Therapeutic advances of miRNAs: a preclinical and clinical update","volume":"28","author":"Chakraborty","year":"2020","journal-title":"J Adv Res"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1872\/66956031\/eschf_12_3_1872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1872\/66956031\/eschf_12_3_1872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:25:05Z","timestamp":1771406705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/3\/1872\/8488327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15194","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"2024-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}